(Q42623867)

3 November 2017

title

Lamotrigine for the treatment of epilepsy in childhood (English)

1 reference

3 November 2017

1 reference

F M Besag

1

1 reference

3 November 2017

S J Wallace

2

1 reference

3 November 2017

O Dulac

3

1 reference

3 November 2017

J Alving

4

1 reference

3 November 2017

S C Spencer

5

1 reference

3 November 2017

G Hosking

6

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

The Journal of Pediatrics

3 November 2017

published in

1 reference

3 November 2017

volume

127

1 reference

3 November 2017

issue

6

1 reference

3 November 2017

page(s)

991-997

1 reference

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

Children of school age: the influence of antiepileptic drugs on behavior and intellect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

Hepatotoxic reactions associated with carbamazepine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

Adverse effects of valproate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

Lamotrigine in treatment of 120 children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

Lamotrigine clinical pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970047-1

10.1016/S0022-3476(95)70047-1

7 January 2021

Identifiers

DOI

1 reference

3 November 2017

1 reference